BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29155984)

  • 41. Variability in High-Sensitivity Cardiac Troponin T Testing in Stable Patients With and Without Coronary Artery Disease.
    Brophy JM; Dagenais GR; Boyer L; Garcia-Labbé D; Bogaty P
    Can J Cardiol; 2019 Nov; 35(11):1505-1512. PubMed ID: 31679620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes: PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice).
    Van Belle E; Baptista SB; Raposo L; Henderson J; Rioufol G; Santos L; Pouillot C; Ramos R; Cuisset T; Calé R; Teiger E; Jorge E; Belle L; Machado C; Barreau D; Costa M; Hanssen M; Oliveira E; Besnard C; Costa J; Dallongeville J; Pipa J; Sideris G; Fonseca N; Bretelle C; Guardado J; Lhoest N; Silva B; Barnay P; Sousa MJ; Leborgne L; Silva JC; Vincent F; Rodrigues A; Seca L; Fernandes R; Dupouy P;
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28615234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic performance of high sensitive troponin in non-ST elevation acute coronary syndrome.
    Velilla Moliner J; Gros Bañeres B; Povar Marco J; Santaló Bel M; Ordoñez Llanos J; Martín Martín A; Temboury Ruiz F
    Med Intensiva (Engl Ed); 2020 Mar; 44(2):88-95. PubMed ID: 30249382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do ANGPTL-4 and galectin-3 reflect the severity of coronary artery disease?
    Goenka L; George M; Singh V; Jena A; Seshadri D; Karunakaran V; Elumalai DV; Rani J; Kaliappan I
    Ther Adv Cardiovasc Dis; 2017 Oct; 11(10):261-270. PubMed ID: 28795637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of serum N-Acetylneuraminic acid with the risk and prognosis of acute coronary syndrome: a prospective cohort study.
    Li MN; Qian SH; Yao ZY; Ming SP; Shi XJ; Kang PF; Zhang NR; Wang XJ; Gao DS; Gao Q; Zhang H; Wang HJ
    BMC Cardiovasc Disord; 2020 Sep; 20(1):404. PubMed ID: 32912159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fast assessment and management of chest pain without ST-elevation in the pre-hospital gateway: rationale and design.
    Ishak M; Ali D; Fokkert MJ; Slingerland RJ; Dikkeschei B; Tolsma RT; Lichtveld RA; Bruins W; Boomars R; Bruheim K; van Eenennaam F; Timmers L; Voskuil M; Doevendans PA; Mosterd A; Hoes AW; ten Berg JM; van 't Hof AW;
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):129-36. PubMed ID: 25202026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heart-type fatty acid-binding protein: an overlooked cardiac biomarker.
    Goel H; Melot J; Krinock MD; Kumar A; Nadar SK; Lip GYH
    Ann Med; 2020 Dec; 52(8):444-461. PubMed ID: 32697102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome.
    Widera C; Pencina MJ; Bobadilla M; Reimann I; Guba-Quint A; Marquardt I; Bethmann K; Korf-Klingebiel M; Kempf T; Lichtinghagen R; Katus HA; Giannitsis E; Wollert KC
    Clin Chem; 2013 Oct; 59(10):1497-505. PubMed ID: 23818444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up.
    Alnasser SM; Huang W; Gore JM; Steg PG; Eagle KA; Anderson FA; Fox KA; Gurfinkel E; Brieger D; Klein W; van de Werf F; Avezum Á; Montalescot G; Gulba DC; Budaj A; Lopez-Sendon J; Granger CB; Kennelly BM; Goldberg RJ; Fleming E; Goodman SG;
    Am J Med; 2015 Jul; 128(7):766-75. PubMed ID: 25554379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving risk stratification in non-ST-segment elevation myocardial infarction with combined assessment of GRACE and CRUSADE risk scores.
    Paiva L; Providência R; Barra SN; Dinis P; Faustino AC; Costa M; Gonçalves L
    Arch Cardiovasc Dis; 2014 Dec; 107(12):681-9. PubMed ID: 25219759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical predictors of 30-day cardiac events in patients with acute coronary syndrome at a community hospital.
    Tadros GM; McConnell TR; Wood GC; Costello JM; Iliadis EA
    South Med J; 2003 Nov; 96(11):1113-20. PubMed ID: 14632360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes.
    Manenti ER; Bodanese LC; Camey SA; Polanczyk CA
    Clin Cardiol; 2006 Sep; 29(9):405-10. PubMed ID: 17007172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study on the levels of uric acid and high-sensitivity C-reactive protein in ACS patients and their relationships with the extent of the coronary artery lesion.
    Ma QQ; Yang XJ; Yang NQ; Liu L; Li XD; Zhu K; Fu Q; Wei P
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4294-4298. PubMed ID: 27831644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Comparison of Prognostic Value of the Levels of ProBNP and Troponin T in Patients with Acute Coronary Syndrome (ACS).
    Vogiatzis I; Dapcevic I; Datsios A; Koutsambasopoulos K; Gontopoulos A; Grigoriadis S
    Med Arch; 2016 Jul; 70(4):269-273. PubMed ID: 27703287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single vs Serial Measurements of Cardiac Troponin Level in the Evaluation of Patients in the Emergency Department With Suspected Acute Myocardial Infarction.
    Wassie M; Lee MS; Sun BC; Wu YL; Baecker AS; Redberg RF; Ferencik M; Shen E; Musigdilok V; Sharp AL
    JAMA Netw Open; 2021 Feb; 4(2):e2037930. PubMed ID: 33620444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contemporary NSTEMI management: the role of the hospitalist.
    Pollack CV; Amin A; Wang T; Deitelzweig S; Cohen M; Slattery D; Fanikos J; DiLascia C; Tuder R; Kaatz S
    Hosp Pract (1995); 2020 Feb; 48(1):1-11. PubMed ID: 31815570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromes.
    Lim KD; Yan AT; Casanova A; Yan RT; Mendelsohn A; Jolly S; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2008 Apr; 155(4):718-24. PubMed ID: 18371482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk stratification and prognostic value of GRACE and TIMI risk scores for female patients with non-ST segment elevation acute coronary syndrome.
    Zhu H; Xue H; Wang H; Chen Y; Zhou S; Tian F; Hu S; Wang J; Yang J; Zhang T
    Minerva Cardioangiol; 2015 Jun; 63(3):171-8. PubMed ID: 25501977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome.
    Goodacre S; Thokala P; Carroll C; Stevens JW; Leaviss J; Al Khalaf M; Collinson P; Morris F; Evans P; Wang J
    Health Technol Assess; 2013; 17(1):v-vi, 1-188. PubMed ID: 23331845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.
    Samman Tahhan A; Hammadah M; Raad M; Almuwaqqat Z; Alkhoder A; Sandesara PB; Mohamed-Kelli H; Hayek SS; Kim JH; O'Neal WT; Topel ML; Grant AJ; Sabbak N; Heinl RE; Gafeer MM; Obideen M; Kaseer B; Abdelhadi N; Ko YA; Liu C; Hesaroieh I; Mahar EA; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2018 May; 122(11):1565-1575. PubMed ID: 29514830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.